Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,280.00
(
-0.67%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
99.11
(
-0.75%
)
Bitcoin
70,761.32
(
-0.02%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122862
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: moneyman1010 post# 17218

Friday, 03/16/2012 2:36:56 PM

Friday, March 16, 2012 2:36:56 PM

Post# of 80490

RACHEL MCMINN thinks no approval. hopefully wrong like the rest of her calls.

She may be wrong on this matter, but McMinn has one of the best track records overall of any biotech sell-side analyst.

p.s. Taltorvic is one of the worst brand names I’ve ever heard (#msg-73348538).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today